Beyond low tidal volume ventilation: Treatment adjuncts for severe respiratory failure in acute respiratory distress syndrome

Critical Care Medicine

Volumn 46, Issue 11, 2018, Pages 1820-1831

  Fielding Singh, Vikram ^a   Matthay, Michael A ^b   Calfee, Carolyn S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Mechanical ventilation; Neuromuscular blockade; Rescue therapies

Indexed keywords

GLUCOCORTICOID; NITRIC OXIDE; PROSTAGLANDIN;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CORTICOSTEROID THERAPY; EVIDENCE BASED PRACTICE; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY OSCILLATORY VENTILATION; HUMAN; HYPOXEMIA; NEUROMUSCULAR BLOCKING; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PRONE POSITION; REFRACTORY HYPOXEMIA; RENAL REPLACEMENT THERAPY; RESPIRATORY ACIDOSIS; RESPIRATORY FAILURE; THORAX PRESSURE; TIDAL VOLUME VENTILATION; EVIDENCE BASED MEDICINE; HIGH FREQUENCY VENTILATION; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

EVIDENCE-BASED MEDICINE; EXTRACORPOREAL MEMBRANE OXYGENATION; HIGH-FREQUENCY VENTILATION; HUMANS; POSITIVE-PRESSURE RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 85054896316     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000003406     Document Type: Article

References (119)

1. Ashbaugh DG, Bigelow DB, Petty TL, et al: Acute respiratory distress in adults. Lancet 1967; 2:319-323
2. Bellani G, Laffey JG, Pham T, et al; LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315:788-800
3. Brower RG, Matthay MA, Morris A, et al: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
4. Fan E, Del Sorbo L, Goligher EC, et al; American Thoracic Society, European Society of Intensive Care Medicine, and Society of Critical Care Medicine: An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195:1253-1263
5. Ranieri VM, Rubenfeld GD, Thompson BT, et al; ARDS Definition Task Force: Acute respiratory distress syndrome: The Berlin definition. JAMA 2012; 307:2526-2533
6. Guérin C, Reignier J, Richard JC, et al; PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368:2159-2168
7. Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-1116
8. Kangelaris KN, Calfee CS, May AK, et al: Is there still a role for the lung injury score in the era of the Berlin definition ARDS? Ann Intensive Care 2014; 4:4
9. Duan EH, Adhikari NKJ, D'Aragon F, et al; Canadian Critical Care Trials Group: Management of acute respiratory distress syndrome and refractory hypoxemia. A multicenter observational study. Ann Am Thorac Soc 2017; 14:1818-1826
10. Radermacher P, Maggiore SM, Mercat A: Fifty years of research in ARDS. Gas exchange in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196:964-984
11. Nin N, Muriel A, Peñuelas O, et al; VENTILA Group: Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med 2017; 43:200-208
12. Nuckton TJ, Alonso JA, Kallet RH, et al: Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002; 346:1281-1286
13. Cepkova M, Kapur V, Ren X, et al: Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. Chest 2007; 132:836-842
14. Henderson WR, Chen L, Amato MBP, et al: Fifty years of research in ARDS. Respiratory mechanics in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196:822-833
15. Slutsky AS, Ranieri VM: Ventilator-induced lung injury. N Engl J Med 2014; 370:980
16. Amato MB, Meade MO, Slutsky AS, et al: Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015, 372
17. Villar J, Martín-Rodríguez C, Domínguez-Berrot AM, et al; Spanish Initiative for Epidemiology, Stratification and Therapies for ARDS (SIESTA) Investigators Network: A quantile analysis of plateau and driving pressures: Effects on mortality in patients with acute respiratory distress syndrome receiving lung-protective ventilation. Crit Care Med 2017; 45:843-850
18. Young D, Lamb SE, Shah S, et al; OSCAR Study Group: Highfrequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013; 368:806-813
19. Ferguson ND, Cook DJ, Guyatt GH, et al; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group: High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368:795-805
20. Sahetya SK, Goligher EC, Brower RG: Fifty years of research in ARDS. Setting positive end-expiratory pressure in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195:1429-1438
21. Brower RG, Lanken PN, MacIntyre N, et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327-336
22. Meade MO, Cook DJ, Guyatt GH, et al; Lung Open Ventilation Study Investigators: Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008; 299:637-645
23. Mercat A, Richard JC, Vielle B, et al; Expiratory Pressure (Express) Study Group: Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008; 299:646-655
24. Talmor D, Sarge T, Malhotra A, et al: Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 2008; 359:2095-2104
25. Hodgson CL, Tuxen DV, Davies AR, et al: A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome. Crit Care 2011; 15:R133
26. Kacmarek RM, Villar J, Sulemanji D, et al; Open Lung Approach Network: Open lung approach for the acute respiratory distress syndrome: A pilot, randomized controlled trial. Crit Care Med 2016; 44:32-42
27. Cavalcanti AB, Suzumura EA, Laranjeira LN, et al: Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: A randomized clinical trial. JAMA 2017; 318:1335-1345
28. Briel M, Meade M, Mercat A, et al: Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: Systematic review and meta-analysis. JAMA 2010; 303:865-873
29. Walkey AJ, Del Sorbo L, Hodgson CL, et al: Higher PEEP versus Lower PEEP strategies for patients with acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14:S297-S303
30. Goligher EC, Kavanagh BP, Rubenfeld GD, et al: Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med 2014; 190:70-76
31. Aoyama H, Pettenuzzo T, Aoyama K, et al: Association of driving pressure with mortality among ventilated patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care Med 2018; 46:300-306
32. MacIntyre N: Ventilator management guided by driving pressure: A better way to protect the lungs? Crit Care Med 2018; 46:338-339
33. Gattinoni L, Caironi P, Cressoni M, et al: Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:1775-1786
34. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protectiveventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354
35. Brower RG, Rubenfeld GD: Lung-protective ventilation strategies in acute lung injury. Crit Care Med 2003; 31:S312-S316
36. Xi XM, Jiang L, Zhu B; RM group: Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: A multicenter randomized controlled clinical trial. Chin Med J (Engl) 2010; 123:3100-3105
37. Hodgson C, Goligher EC, Young ME, et al: Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation. Cochrane Database Syst Rev 2016; 11:CD006667
38. Suzumura EA, Figueiró M, Normilio-Silva K, et al: Effects of alveolar recruitment maneuvers on clinical outcomes in patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Intensive Care Med 2014; 40:1227-1240
39. Goligher EC, Hodgson CL, Adhikari NKJ, et al: Lung recruitment maneuvers for adult patients with acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14:S304-S311
40. Borges JB, Okamoto VN, Matos GF, et al: Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 174:268-278
41. Wiedemann HP, Wheeler AP, Bernard GR, et al; National Heart Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Nework: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
42. Sud S, Sud M, Friedrich JO, et al: High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): Systematic review and meta-analysis. BMJ 2010; 340:c2327
43. Sud S, Sud M, Friedrich JO, et al: High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2013; (2):CD004085
44. Mentzelopoulos SD, Malachias S, Zintzaras E, et al: Intermittent recruitment with high-frequency oscillation/tracheal gas insufflation in acute respiratory distress syndrome. Eur Respir J 2012; 39:635-647
45. Sud S, Sud M, Friedrich JO, et al: High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome. Cochrane Database Syst Rev 2016; 4:CD004085
46. Maitra S, Bhattacharjee S, Khanna P, et al: High-frequency ventilation does not provide mortality benefit in comparison with conventional lung-protective ventilation in acute respiratory distress syndrome: A meta-analysis of the randomized controlled trials. Anesthesiology 2015; 122:841-851
47. Goligher EC, Munshi L, Adhikari NKJ, et al: High-frequency oscillation for adult patients with acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14:S289-S296
48. Meade MO, Young D, Hanna S, et al: Severity of hypoxemia and effect of high-frequency oscillatory ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196:727-733
49. Dreyfuss D, Basset G, Soler P, et al: Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985; 132:880-884
50. Dreyfuss D, Soler P, Basset G, et al: High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137:1159-1164
51. Webb HH, Tierney DF: Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure. Am Rev Respir Dis 1974; 110:556-565
52. Parker JC, Townsley MI, Rippe B, et al: Increased microvascular permeability in dog lungs due to high peak airway pressures. J Appl Physiol Respir Environ Exerc Physiol 1984; 57:1809-1816
53. Sahetya SK, Brower RG: Lung recruitment and titrated PEEP in moderate to severe ARDS: Is the door closing on the open lung? JAMA 2017; 318:1327-1329
54. Forel JM, Roch A, Marin V, et al: Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34:2749-2757
55. Gainnier M, Roch A, Forel JM, et al: Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32:113-119
56. Alhazzani W, Alshahrani M, Jaeschke R, et al: Neuromuscular blocking agents in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials. Crit Care 2013; 17:R43
57. Murray MJ, DeBlock H, Erstad B, et al: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2016; 44:2079-2103
58. Kress JP, Hall JB: ICU-acquired weakness and recovery from critical illness. N Engl J Med 2014; 370:1626-1635
59. De Jonghe B, Sharshar T, Lefaucheur JP, et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-2867
60. Bouju P, Tadié JM, Barbarot N, et al: Clinical assessment and train-offour measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: A prospective descriptive study. Ann Intensive Care 2017; 7:10
61. Gattinoni L, Tognoni G, Pesenti A, et al; Prone-Supine Study Group: Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001; 345:568-573
62. Taccone P, Pesenti A, Latini R, et al; Prone-Supine II Study Group: Prone positioning in patients with moderate and severe acute respiratory distress syndrome: A randomized controlled trial. JAMA 2009; 302:1977-1984
63. Guerin C, Gaillard S, Lemasson S, et al: Effects of systematic prone positioning in hypoxemic acute respiratory failure: A randomized controlled trial. JAMA 2004; 292:2379-2387
64. Mancebo J, Fernández R, Blanch L, et al: A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 173:1233-1239
65. Ferguson ND, Thompson BT: Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: No. Intensive Care Med 2015; 41:2198-2200
66. Bloomfield R, Noble DW, Sudlow A: Prone position for acute respiratory failure in adults. Cochrane Database Syst Rev 2015; (11):CD008095
67. Sud S, Friedrich JO, Adhikari NK, et al: Effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome: A systematic review and meta-analysis. CMAJ 2014; 186:E381-E390
68. Lee JM, Bae W, Lee YJ, et al: The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: Updated study-level meta-analysis of 11 randomized controlled trials. Crit Care Med 2014; 42:1252-1262
69. Beitler JR, Shaefi S, Montesi SB, et al: Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: A meta-analysis. Intensive Care Med 2014; 40:332-341
70. Munshi L, Del Sorbo L, Adhikari NKJ, et al: Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14:S280-S288
71. Gattinoni L, Marini JJ: Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: We are not sure. Intensive Care Med 2015; 41:2201-2203
72. Guérin C, Mancebo J: Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: Yes. Intensive Care Med 2015; 41:2195-2197
73. Levy SD, Alladina JW, Hibbert KA, et al: High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet 2016; 387:1867-1878
74. Taylor RW, Zimmerman JL, Dellinger RP, et al; Inhaled Nitric Oxide in ARDS Study Group: Low-dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial. JAMA 2004; 291:1603-1609
75. Adhikari NK, Dellinger RP, Lundin S, et al: Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: Aystematic review and meta-analysis. Crit Care Med 2014; 42:404-412
76. Gebistorf F, Karam O, Wetterslev J, et al: Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev 2016; (6):CD002787
77. Afshari A, Bastholm Bille A, Allingstrup M: Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS). Cochrane Database Syst Rev 2017; 7:CD007733
78. Fuller BM, Mohr NM, Skrupky L, et al: The use of inhaled prostaglandins in patients with ARDS: A systematic review and meta-analysis. Chest 2015; 147:1510-1522
79. Christenson J, Lavoie A, O'Connor M, et al: The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000; 161:1443-1449
80. Gerlach H, Keh D, Semmerow A, et al: Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: A prospective, randomized, controlled study. Am J Respir Crit Care Med 2003; 167:1008-1015
81. Rhodes A, Evans LE, Alhazzani W, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45:486-552
82. Keh D, Trips E, Marx G, et al; SepNet-Critical Care Trials Group: Effect of hydrocortisone on development of shock among patients with severe sepsis: The HYPRESS randomized clinical trial. JAMA 2016; 316:1775-1785
83. Venkatesh B, Finfer S, Cohen J, et al: Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018; 378:797-808
84. Siemieniuk RA, Meade MO, Alonso-Coello P, et al: Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: A systematic review and meta-analysis. Ann Intern Med 2015; 163:519-528
85. McGee S, Hirschmann J: Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008; 168:1034-1046
86. Wieruszewski PM, Barreto JN, Frazee E, et al: Early corticosteroids for pneumocystis pneumonia in adults without hiv are not associated with better outcome. Chest 2018 Apr 26. [Epub ahead of print]
87. Bernard GR, Luce JM, Sprung CL, et al: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317:1565-1570
88. Meduri GU, Golden E, Freire AX, et al: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 2007; 131:954-963
89. Steinberg KP, Hudson LD, Goodman RB, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684
90. Meduri GU, Headley AS, Golden E, et al: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial. JAMA 1998; 280:159-165
91. Bein T, Briegel J, Annane D: Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: Yes. Intensive Care Med 2016; 42:918-920
92. Seam N, Suffredini AF: Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: We are not sure. Intensive Care Med 2016; 42:924-927
93. Thompson BT, Ranieri VM: Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: No. Intensive Care Med 2016; 42:921-923
94. Meduri GU, Bridges L, Siemieniuk RAC, et al: An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome. Crit Care Med 2018; 46:884-891
95. Peter JV, John P, Graham PL, et al: Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis. BMJ 2008; 336:1006-1009
96. Meduri GU, Bridges L, Shih MC, et al: Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 2016; 42:829-840
97. Ruan SY, Lin HH, Huang CT, et al: Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care 2014; 18:R63
98. Horita N, Hashimoto S, Miyazawa N, et al: Impact of corticosteroids on mortality in patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Intern Med 2015; 54:1473-1479
99. Yang ZG, Lei XL, Li XL: Early application of low-dose glucocorticoid improves acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. Exp Ther Med 2017; 13:1215-1224
100. Tongyoo S, Permpikul C, Mongkolpun W, et al: Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial. Crit Care 2016; 20:329
101. Brun-Buisson C, Richard JC, Mercat A, et al; REVA-SRLF A/H1N1v 2009 Registry Group: Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183:1200-1206
102. Hashimoto S, Sanui M, Egi M, et al; ARDS clinical practice guideline committee from the Japanese Society of Respiratory Care Medicine and the Japanese Society of Intensive Care Medicine: The clinical practice guideline for the management of ARDS in Japan. J Intensive Care 2017; 5:50
103. Annane D, Pastores SM, Rochwerg B, et al: Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med 2017; 45:2078-2088
104. Cho YJ, Moon JY, Shin ES, et al; Korean Society of Critical Care Medicine; Korean Academy of Tuberculosis and Respiratory Diseases Consensus Group: Clinical practice guideline of acute respiratory distress syndrome. Tuberc Respir Dis (Seoul) 2016; 79:214-233
105. Claesson J, Freundlich M, Gunnarsson I, et al: Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome. Acta Anaesthesiol Scand 2016; 60:697-709
106. Silversides JA, Major E, Ferguson AJ, et al: Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: A systematic review and meta-analysis. Intensive Care Med 2017; 43:155-170
107. Ronco C, Bonello M, Bordoni V, et al: Extracorporeal therapies in non-renal disease: Treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004; 22:164-174
108. Matsuda K, Moriguchi T, Oda S, et al: Efficacy of continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of acute respiratory distress syndrome. Contrib Nephrol 2010; 166:83-92
109. Han F, Sun R, Ni Y, et al: Early initiation of continuous renal replacement therapy improves clinical outcomes in patients with acute respiratory distress syndrome. Am J Med Sci 2015; 349:199-205
110. Putzu A, Fang MX, Boscolo Berto M, et al: Blood purification with continuous veno-venous hemofiltration in patients with sepsis or ARDS: A systematic review and meta-analysis. Minerva Anestesiol 2017; 83:867-877
111. Zapol WM, Snider MT, Hill JD, et al: Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242:2193-2196
112. Noah MA, Peek GJ, Finney SJ, et al: Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306:1659-1668
113. Pham T, Combes A, Rozé H, et al; REVA Research Network: Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: A cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013; 187:276-285
114. Tramm R, Ilic D, Davies AR, et al: Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev 2015; 1:CD010381
115. Davies A, Jones D, Bailey M, et al; Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators: Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302:1888-1895
116. Combes A, Hajage D, Capellier G, et al; EOLIA Trial Group, REVA, and ECMONet: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378:1965-1975
117. Abrams D, Brodie D: Extracorporeal Membrane Oxygenation for Adult Respiratory Failure: 2017 Update. Chest 2017; 152:639-649
118. Vaquer S, de Haro C, Peruga P, et al: Systematic review and metaanalysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome. Ann Intensive Care 2017; 7:51
119. Schmidt M, Schellongowski P, Patroniti N, et al: Six-month outcome of immunocompromised severe ARDS patients rescued by ECMO. An international multicenter retrospective study. Am J Respir Crit Care Med 2018 Jan 3. [Epub ahead of print]